RecruitingPhase 2NCT04696029
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Studying Medulloblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Giselle Sholler
- Principal Investigator
- Michael A Huang, MDBeat Childhood Cancer
- Intervention
- Difluoromethylornithine(drug)
- Enrollment
- 118 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2021 – 2029
Study locations (23)
- Arkansas Children's Hospital, Little Rock, Arkansas, United States
- UCSF Benioff Children's Hospital Oakland, Oakland, California, United States
- Rady Children's Hospital, San Diego, California, United States
- Stanford University, Stanford, California, United States
- Connecticut Children's Hospital, Hartford, Connecticut, United States
- Nicklaus Children's Hospital, Miami, Florida, United States
- Arnold Palmer Hospital for Children, Orlando, Florida, United States
- All Children's Hospital Johns Hopkins Medicine, St. Petersburg, Florida, United States
- St. Joseph's Children's Hospital, Tampa, Florida, United States
- Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States
- Advocate Aurora Research Institute, Chicago, Illinois, United States
- Kentucky Children's Hospital, Lexington, Kentucky, United States
- Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine, Louisville, Kentucky, United States
- Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States
- Cardinal Glennon Children's Medical Center, St Louis, Missouri, United States
- +8 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04696029 on ClinicalTrials.govOther trials for Medulloblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07085325CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal IrradiationSt. Jude Children's Research Hospital
- RECRUITINGPHASE2NCT06701812Digoxin Medulloblastoma StudyH. Lee Moffitt Cancer Center and Research Institute
- RECRUITINGNANCT06898684Medulloblastoma Online Video-based Exercise Pilot StudyAron Onerup
- RECRUITINGNCT07242963Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry StudyMohammad H. Abu Arja
- RECRUITINGEARLY PHASE1NCT06942039Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationC17 Council
- ACTIVE NOT RECRUITINGPHASE1NCT06514898Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With MedulloblastomaUniversity of Florida
- RECRUITINGNCT06779487Systemic Biomarkers to Predict Radiation-Induced Neurocognitive DeclineTata Memorial Centre
- RECRUITINGEARLY PHASE1NCT06959979Novel Molecular Targets and Innovative Therapeutic Perspective in MedulloblastomaFondazione Policlinico Universitario Agostino Gemelli IRCCS